| Patient | Leonardo da Vinci |
|---|---|
| Date of birth | 1961-04-24 |
| Identifiers | MRN HR-RE001-SYN; SSN (made up) 000-01-5297 |
| Document date | 2026-10-20 |
| Author | Beatrice Carrow-Asante, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Nine-week review of the ulnar neuropathy and lipids; decision about surgery. [S]
Mr. da Vinci returns nine weeks after the diagnosis, about fifteen weeks after the fall. He has worn both splints faithfully and has had fourteen sessions of hand therapy. The numbness of the little finger is much less. His grip is a little stronger, but the ring and little fingers still curl when he reaches for a brush, and he still cannot hold the palette in his right hand for more than a few minutes; fine brushwork with the right hand is beyond him. He draws, writes, and teaches every day with his left hand and paints small panels with a palette fixed to the easel and built-up brushes, with an assistant mixing colors. He takes atorvastatin each evening without muscle aches. He has had no further falls. [S]
| Element | Detail |
|---|---|
| Splints and therapy | Both splints worn; fourteen hand-therapy sessions |
| Symptoms | Numbness much less; grip slightly stronger; clawing persists |
| Function | Drawing, writing, and teaching with the left hand; painting small panels with adapted tools |
| Statin | Nine weeks; no muscle aches |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Little-finger numbness much improved; persistent weakness of the right hand; no new symptoms |
| Musculoskeletal | Negative | No muscle aches; no elbow pain |
| Cardiovascular | Negative | No chest pain or palpitations |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for elbow pain, no more than 3 g a day | One or two tablets every 6 hours as needed; no more than six tablets a day | Oral route | 2026-08-03 to 2026-09-14 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth each evening | One tablet by mouth each evening | Oral route | 2026-08-17 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-20 | Body height | 175 | cm | S |
| 2026-10-20 | Body weight | 73.6 | kg | S |
| 2026-10-20 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 2026-10-20 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-20 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-20 | Heart rate | 66 | /min | S |
| 2026-10-20 | Respiratory rate | 14 | /min | S |
| 2026-10-20 | Body temperature | 36.5 | Cel | S |
| 2026-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-20 | Cholesterol [Mass/volume] in Serum or Plasma | 158 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 51 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-10-20 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 82 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-20 | Triglyceride [Mass/volume] in Serum or Plasma | 124 | mg/dL | <=149 mg/dL | Normal | S |
Vital signs recorded on 2026-10-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Right hand | Two-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor of the little finger 4+/5; Froment sign still positive; clawing of the ring and little fingers persists; first web wasting unchanged |
| Right elbow | Tinel sign weaker; elbow flexion test positive at 45 seconds; nerve does not sublux |
| Cardiovascular | Blood pressure 124/74 mmHg; regular pulse |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Weakness, numbness of the ring and little fingers, and curling of those fingers in the right hand for four weeks after a fall onto the right elbow, in a left-handed artist who uses the right hand for the palette and brushwork; stroke and a peripheral nerve lesion under evaluation | resolved | confirmed | R29.818 | S — Synthetic presenting concern; it echoes, without asserting, the paralysis of his right hand recorded later in 1517 (CLM-0006). Superseded by the diagnosis at the second visit. |
| One fall in the past year (slipped on stone stairs and landed on the right elbow), with no loss of consciousness, dizziness, or palpitations before it; fall risk | active | confirmed | Z91.81 | S — Synthetic fall that anchors the modern ulnar nerve injury; no historical fall is asserted. |
| Ulnar neuropathy at the right elbow (cubital tunnel), post-traumatic, moderately severe: sensory loss in the ulnar fingers and dorsal ulnar hand, weakness and early wasting of the intrinsic hand muscles with clawing of the ring and little fingers, focal slowing and partial conduction block across the elbow, and active denervation on EMG; stroke, C8 radiculopathy, and lower trunk plexopathy excluded | active | confirmed | G56.21 | S — Synthetic modern diagnosis. The paralysis of his right hand in 1517 is documented (D); its cause is unknown, and ulnar palsy, stroke, and median nerve palsy are competing retrospective readings (R). |
| Primary hypercholesterolemia (LDL 146 mg/dL) with a Pooled Cohort Equations 10-year ASCVD risk of 13.5 percent (PREVENT 6.9 percent); found on the stroke risk screen | active | confirmed | E78.00 | S — Synthetic risk factor found on the stroke risk screen; no historical lipid disorder is asserted. |
| Acute viral conjunctivitis, both eyes, after exposure to a student with red eyes; vision normal; resolved | resolved | confirmed | B30.9 | S — Synthetic intercurrent illness at an unscheduled visit; no historical eye disease is asserted. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Ulnar motor and sensory examination: strength of the first dorsal interosseous, abductor digiti minimi, and deep flexor of the little finger (MRC grade), two-point discrimination of the little finger, Froment and Wartenberg signs, clawing, and wasting | Every visit during treatment | Completed today | Two-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor 4+/5; clawing persists |
| Examination | Grip and key-pinch dynamometry, both hands | Every visit during treatment | Completed today | Grip 24 kg right, 38 kg left; key pinch 3.8 kg right |
| Survey | Patient-reported hand function (QuickDASH) | Before treatment, then at each review | Completed today | 41 of 100, from 52 |
| Self-management | Splint use and avoiding pressure on and prolonged bending of the elbow | Every visit during treatment | Completed today | Both splints worn; elbow pad in use |
| Referral | Hand therapy | Twice a week from diagnosis | Completed today | Fourteen sessions; continues until surgery |
| Referral | Surgical review at about three months for persistent weakness | At about three months from the injury | Completed today | Decompression chosen and booked |
| Medication safety | Corticosteroid injection at the cubital tunnel | Not part of treatment | Not indicated | No benefit over placebo at three months in the Cochrane review |
| Laboratory | Lipid panel after starting a statin | 4 to 12 weeks after starting or changing | Completed today | LDL 82 mg/dL, 44 percent below baseline; total cholesterol 158, HDL 51, triglycerides 124 mg/dL |
| Laboratory | ALT on a statin | Baseline only; then if symptoms | Not indicated | Normal at baseline; no symptoms |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | No missed doses; no muscle aches |
| Examination | Blood pressure, weight, and smoking status | Every visit | Completed today | 124/74 mmHg; 73.6 kg; never smoker |
Goal progress:
Guideline basis: Cubital Tunnel Syndrome (Ulnar Nerve Entrapment at the Elbow), OrthoInfo (2026); Treatment for ulnar neuropathy at the elbow (Caliandro P, et al.) (2025); Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow: summary statement (American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation) (1999); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, hyperlipidemia monograph (2026)
Follow-up: Surgery in three weeks; post-operative review with the hand surgeon at two weeks and primary care review after that; lipid panel in a year. [S]